Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-04-11
2006-04-11
Wilson, James O. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S185000, C424S009362, C424S009610, C540S145000, C534S015000
Reexamination Certificate
active
07026347
ABSTRACT:
Porphyrin-polyamine conjugate compounds are disclosed which have anticancer and antitumor effects. The porphyrin moiety selectively localizes in tumors, while the polyamine moiety serves as a cytotoxic agent. Methods of making and using the porphyrin-polyamine conjugate compounds are also disclosed.
REFERENCES:
patent: 4443604 (1984-04-01), Lee
patent: 4784736 (1988-11-01), Lonsdale et al.
patent: 5275801 (1994-01-01), Niedballa et al.
patent: 5912341 (1999-06-01), Hoffman et al.
patent: 6114321 (2000-09-01), Platzek et al.
patent: 6207660 (2001-03-01), Sessler et al.
patent: 6395257 (2002-05-01), Achilefu et al.
patent: 6906050 (2005-06-01), Robinson
patent: 2002/0155999 (2002-10-01), Han
patent: 2003/0036538 (2003-02-01), Rajagopalan et al.
patent: 2003/0100752 (2003-05-01), Robinson
patent: 2004/0192665 (2004-09-01), Frydman et al.
patent: WO 00/66587 (2000-11-01), None
patent: WO 200066587 (2000-11-01), None
patent: WO-02/10142 (2002-02-01), None
patent: WO-03/004091 (2003-01-01), None
patent: WO-03/004091 (2003-01-01), None
patent: WO-03/004466 (2003-01-01), None
patent: WO-03/004466 (2003-01-01), None
patent: WO-03/051348 (2003-06-01), None
patent: WO-2004/002991 (2004-01-01), None
patent: WO-2004/012774 (2004-02-01), None
patent: WO-2004/041828 (2004-05-01), None
Ando, A. et al. (Aug. 1990). “Synthesis of Fluorine Analogues of Protoporphyrin Potentially Useful for Diagnosis and Therapy of Tumors,”Chemical and Pharmaceutical Bulletin38(8):2175-2178.
Brunner, H. et al. (1994). “Platinum(II) Complexes With Porphyrin Ligands—Additive Cytotoxic and Photodynamic Effect,”Angew. Chem. Int. Ed. Engl, 33(21):2214-2215.
Kramer, D.L. et al. (Dec. 15, 1997). “Effects of Novel Spermine Analogues on Cell Cycle Progression and Apoptosis in MALME-3M Human Melanoma Cells,”Cancer Research57:5521-5527.
Sharma, A. et al. (Aug. 1997). “Antitumor Efficacy of N1, N11-Diethylnorspermine on a Human Bladder Tumor Xenograft in Nude Athymic Mice,”Clinical Cancer Research3:1239-1244.
Stemberg, E. et al. (Aug. 1996), “Pyrrolic Photosensitizers,”Current Medicinal Chemistry3(4):239-272.
Wamser, C.C. et al. (1989), “Thin-Film Composite Membranes for Artificial Photosynthesis. Final Report, July 15, 1985-Mar. 31, 1989,”National Technical Information Service, 41 pages.
Basu Hirak S.
Bhattacharya Subhra
Blokhin Andrei V.
Frydman Benjamin
Marton Laurence J.
CellGate, Inc.
Fedowitz Matthew L.
LandOfFree
Porphyrin-polyamine conjugates for cancer therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Porphyrin-polyamine conjugates for cancer therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Porphyrin-polyamine conjugates for cancer therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3611760